Pfizer’s Inlyta gains European recommendation
May 28, 2012Sales and Marketing Inlyta. axitinib, Sutent, renal cell carcinoma
Pfizer’s kidney cancer pill Inlyta has been recommended for use by a European committee. The Committee for Medicinal Products for …
Public-private alliance to discover new antibiotics
May 25, 2012AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection
A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …
Groundbreaking CF drug recommended in Europe
May 25, 2012Sales and Marketing CHMP, EMA, Kalydeco, Vertex, cystic fibrosis
The first-in-class treatment for cystic fibrosis Kalydeco has been recommended by the EMA’s medicines committee. Kalydeco (ivacaftor) promises to be …
CHASE announces two appointments
May 24, 2012Business Services, Medical Communications, Sales and Marketing CHASE, MSI
Contract sales organisation CHASE has announced two appointments to its senior management team. A provider of contract and permanent staff …
Pfizer appoints two senior roles
May 24, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, Read
Pfizer has named Olivier Brandicourt as president and general manager of its Emerging Markets and Established Products Business Units, and …
Two senior moves at Red Door Communications
May 23, 2012Business Services, Medical Communications, Sales and Marketing Red Door Communications, healthcare comms
Red Door Communications has bolstered its senior account handling team by re-hiring Sarah Aldridge as account director. Aldridge (pictured) has …
The ‘colourful’ art of counterfeit packaging
May 23, 2012Manufacturing and Production
The risk to the global pharmaceutical supply chain from counterfeit drugs grows ever year, and costs companies billions in lost …
Boehringer’s COPD drug passes hurdle
May 23, 2012Research and Development, Sales and Marketing Boehringer, COPD, Daxas, Relovair, Spiriva, olodaterol
Boehringer Ingelheim’s once-daily bronchodilator olodaterol has improved lung function versus placebo in a Phase II trial. The manufacturer wants the …
Medical education: pharma’s evolving relationship with healthcare professionals
May 23, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, InPharm, MEP, medical education
There are at least two perspectives of what ‘Medical Education’ means, and certainly many definitions.For doctors and other healthcare professionals, …
AMRI announces president for AMRI Europe
May 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AMRI, AMRI Europe, CMO
Contract research and manufacturing organisation AMRI has announced the appointment of Ian Shott as president of AMRI Europe. In this …
NICE recommends Xarelto for stroke prevention
May 23, 2012Sales and Marketing Bayer, DVT, NICE, Pradaxa, Xarelto, anticoagulant
NICE is recommending Bayer’s anticoagulant pill Xarelto to help reduce the risk of stroke in certain patients. The watchdog’s final …
NHS to host first ‘hack day’ event
May 22, 2012Medical Communications, Sales and Marketing Goldacre, Gray, London, NHS, hack event
The NHS will host its first ‘hack day’ event this weekend in London, with the aim of sharing software that …
Government sets out new information strategy for NHS
May 22, 2012Medical Communications, Sales and Marketing GPs, Lansley, NHS, digital, government, reforms
The Department of Health has outlined its plan for greater use of information technology in the NHS in a bid …
Pharma manufacturing news in brief
May 22, 2012Manufacturing and Production Codexis, IPEC, Novozymes Biopharma, SGS International, Vetter
Excipients trade body IPEC will set up a branch in India next month, plus updates for Codexis, SGS International, Vetter …
MSI appoints new market access consultant
May 22, 2012Business Services, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, appointment, market access
Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …
Gene therapy specialist and Lonza forge production pact
May 22, 2012Manufacturing and Production Avalanche, Lonza, Phil Taylor
Avalanche Biotechnologies, a US company developing gene therapies for ocular diseases, has signed a manufacturing collaboration with Lonza of Switzerland. …
Pharma R&D model no help to developing countries
May 22, 2012Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D
Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …
Pfizer cutting 40% of Premarin plant workforce
May 22, 2012Manufacturing and Production
Pfizer has said it plans to cut 40% of jobs at a manufacturing facility in Manitoba, Canada, that supplies the …
Sir Gordon Duff to host this year’s Clinical Discovery Annual Conference
May 22, 2012Medical Communications, Sales and Marketing
Events 4 Healthcare is delighted that Sir Gordon Duff will be chairing this year’s Clinical Discovery Annual Conference on 16 …
Mitsubishi Tanabe exits API business
May 22, 2012Manufacturing and Production API, Mitsubishi, Phil Taylor, Tanabe
Mitsubishi Tanabe Pharma has said it will withdraw from the fine chemical business, including active pharmaceutical ingredient (API) supply, and …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
